Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 93

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 93
---
 business before the acquisition, including intellectual property infringement claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities; |

| ● | potential disruptions to NewGenIvf’s ongoing businesses; and |

| ● | unexpected costs and unknown risks and liabilities associated with strategic investments or acquisitions. |

Even if the transaction is
consummated, NewGenIvf may only have limited control over the companies in which it only has minority stake, it cannot ensure that these
companies will always comply with applicable laws and regulations in their business operations. Non-compliance of regulatory requirements
by NewGenIvf’s investees may cause substantial harm to NewGenIvf’s reputations and the value of NewGenIvf’s investment.
In addition, if the resulting business from such a transaction fails to meet NewGenIvf’s expectations, or it fails to successfully
integrate such businesses into its own, its business, financial condition and results of operations may be adversely affected or it may
be exposed to unknown risks or liabilities. If NewGenIvf is unable to effectively address these challenges, its ability to execute acquisitions
as a component of its long-term strategy will be impaired, which could have an adverse effect on its growth. As a result of the above,
NewGenIvf’s strategies may not be successfully implemented beyond the current markets.

Any investment might not achieve
the synergies, operational or financial benefits it expects and may adversely impact NewGenIvf’s operating results. In addition,
NewGenIvf cannot assure you that any future investment in or acquisition of new businesses or technology will lead to the successful development
of new or enhanced products and services or that any new or enhanced products and services, if developed, will achieve market acceptance,
or prove to be profitable.

<div align='center'>50</div>

Changes in NewGenIvf’s effective tax rate or tax liability may have an adverse effect on its results of operations.

NewGenIvf’s effective
tax rate could increase due to several factors, including, but not limited to:

| ● | changes in the relative amounts of income before taxes in the various jurisdictions in which NewGenIvf operates that have differing statutory tax rates; |

| ● | changes in tax laws, tax treaties, and regulations or the interpretation of them; |

| ● | changes to its assessment about its ability to realize its deferred tax assets that are based on estimates of its future results, the prudence and feasibility of possible tax planning strategies, and the economic and political environments